Visby Medical, Inc.

United States of America

Back to Profile

1-5 of 5 for Visby Medical, Inc. Sort by
Query
Patent
World - WIPO
Aggregations Reset Report
Date
2023 1
2021 2
Before 2021 2
IPC Class
B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers 2
B01L 7/00 - Heating or cooling apparatusHeat insulating devices 1
B29C 45/00 - Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mouldApparatus therefor 1
C12N 11/04 - Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres 1
C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA 1
See more
Found results for  patents

1.

MOLECULAR DIAGNOSTIC DEVICES AND METHODS FOR RETAINING AND MIXING REAGENTS

      
Application Number US2022040101
Publication Number 2023/018896
Status In Force
Filing Date 2022-08-11
Publication Date 2023-02-16
Owner VISBY MEDICAL, INC. (USA)
Inventor
  • Andreyev, Boris
  • Briones, Victor
  • Ciopyk, Brian
  • Dentinger, Paul
  • Diepersloot, David
  • Loney, Gregory C.
  • Ma, Brandon
  • Mercer, Nicholas S.
  • Patel, Paurav

Abstract

A molecular diagnostic test device can include a housing and a sample preparation module within the housing. The sample preparation module defines an input reservoir and a sample input opening through which a biological sample can be loaded into the input reservoir. The sample preparation module includes a solid reagent contained within the input reservoir. The molecular diagnostic test device can include a fluid source within the housing. The fluid source is in fluid communication with the input reservoir such that upon activation of the molecular diagnostic test device, the fluid from the fluid source is injected into the input reservoir to mix the biological sample and the solid reagent within the input reservoir to form an input solution containing a target molecule.

IPC Classes  ?

  • C12Q 1/6844 - Nucleic acid amplification reactions
  • C12Q 1/6834 - Enzymatic or biochemical coupling of nucleic acids to a solid phase
  • C12N 9/22 - Ribonucleases

2.

DEVICES AND METHODS FOR DETECTION OF TARGET VIRUSES

      
Application Number US2021023781
Publication Number 2021/195150
Status In Force
Filing Date 2021-03-23
Publication Date 2021-09-30
Owner VISBY MEDICAL, INC. (USA)
Inventor
  • Guegler, Karl
  • Swenson, David
  • Roy, Shaunak
  • Dentinger, Paul
  • Ciopyk, Brian
  • Daswani, Samira
  • Schoolnik, Gary
  • Abraham, Teresa

Abstract

A stand-alone molecular diagnostic test device includes a housing, a reverse transcription module, an amplification module, and a detection module. The reverse transcription module is configured to heat a biological sample to produce a target cDNA molecule associated with an RNA virus thereby producing an amplification solution. The amplification module defines a reaction volume configured to receive the amplification solution and amplify the target cDNA molecule within the amplification solution to produce an output. The detection module is configured to receive the output from the amplification module and includes one or more probes specific to a polynucleotide sequence of the RNA virus. The one or more probes is designed to facilitate production of a signal indicating the presence of the RNA virus in the biological sample.

IPC Classes  ?

  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving virus or bacteriophage

3.

DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTIBILITY TESTING

      
Application Number US2020067642
Publication Number 2021/138544
Status In Force
Filing Date 2020-12-31
Publication Date 2021-07-08
Owner VISBY MEDICAL, INC. (USA)
Inventor
  • Ciopyk, Brian
  • Dentinger, Paul
  • Abraham, Teresa
  • Ma, Brandon
  • Kajouke, Kamal
  • Hunt, Mackenzie
  • Phung, Austin

Abstract

e.g.e.g. organism infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.

IPC Classes  ?

  • C12Q 1/18 - Testing for antimicrobial activity of a material
  • B29C 45/00 - Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mouldApparatus therefor
  • C12N 11/04 - Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres

4.

MOLECULAR DIAGNOSTIC DEVICES WITH DIGITAL DETECTION CAPABILITY AND WIRELESS CONNECTIVITY

      
Application Number US2020030307
Publication Number 2020/223257
Status In Force
Filing Date 2020-04-28
Publication Date 2020-11-05
Owner VISBY MEDICAL, INC. (USA)
Inventor
  • Abraham, Teresa
  • Ciopyk, Brian
  • Dentinger, Paul
  • Kajouke, Kamal
  • Knysh, Bryan D.
  • Ma, Brandon

Abstract

In some embodiments, a stand-alone molecular diagnostic test device includes a detection circuit that includes a light emitting device and a light receiving device (e.g., a photodiode) that are arranged to produce an electronic signal associated with a colorimetric output produced by the stand-alone molecular diagnostic test.

IPC Classes  ?

  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • B01L 7/00 - Heating or cooling apparatusHeat insulating devices
  • C12Q 1/37 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving hydrolase involving peptidase or proteinase

5.

DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTIBILITY TESTING

      
Application Number US2019049385
Publication Number 2020/051156
Status In Force
Filing Date 2019-09-03
Publication Date 2020-03-12
Owner VISBY MEDICAL, INC. (USA)
Inventor
  • Swenson, David
  • Cao, Phoebe
  • Schoolnik, Gary
  • Knysh, Bryan D.
  • Abraham, Teresa M.

Abstract

The disclosure relates generally to molecular diagnostic devices configured to amplifying a single nucleotide polymorphism (SNP) locus and discriminate between two or more allelic variants of the SNP, indicating presence or absence of a target allele. In some embodiments, the molecular diagnostic devices are capable of detecting, at point-of-care, SNPs associated with resistance or susceptibility to antibiotic treatment of bacterial infections. In other aspects, the disclosure provides methods of treatment for disease or disorders (e.g. bacterial infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.

IPC Classes  ?

  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
  • C12Q 1/689 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria